Northwest Biotherapeutics, Inc. Stock
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
OTC Markets
15:59:53 2026-06-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.2050 USD | +0.49% |
|
+22.75% | -10.38% |
| Market Cap | 260M 230M 217M 197M 369M 24.96B 373M 2.61B 1B 12.75B 977M 955M 41.01B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 356M 314M 297M 270M 506M 34.18B 511M 3.57B 1.38B 17.45B 1.34B 1.31B 56.16B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 9.89x |
| Free-Float |
95.22% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.49% | ||
| 1 week | +22.75% | ||
| Current month | +20.46% | ||
| 1 month | +8.12% | ||
| 3 months | +5.72% | ||
| 6 months | +0.04% | ||
| Current year | -10.38% |
| 1 week | 0.15 |  | 0.21 |
| 1 month | 0.15 | | 0.21 |
| Current year | 0.14 | | 0.34 |
| 1 year | 0.14 | | 0.34 |
| 3 years | 0.14 | | 0.94 |
| 5 years | 0.14 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 2007-05-31 |
Linda Powers
CEO | Chief Executive Officer | 71 | 2011-06-07 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 1999-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 1997-12-31 |
Linda Powers
CHM | Chairman | 71 | 2007-05-16 |
Navid Malik
BRD | Director/Board Member | 57 | 2012-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/29/24 | Don | Founder | 1,000,000 | 0.0826% | ||
| 8/9/24 | Don | Chief Technology Officer | 3,000,000 | 0.2478% | ||
| 8/8/24 | Don | Founder | 1,000,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.49% | +22.75% | -19.61% | -76.44% | 260M | |
| -0.70% | -4.35% | +56.10% | +86.42% | 71.81B | |
| +0.45% | -0.82% | +38.81% | +84.19% | 60.06B | |
| +0.19% | +0.94% | +36.97% | +21.32% | 27.93B | |
| -1.61% | -4.35% | -18.42% | +357.66% | 25.7B | |
| -1.22% | -2.88% | -0.14% | -9.83% | 24.89B | |
| +0.65% | +1.67% | +26.47% | -7.62% | 20.92B | |
| +3.46% | +3.91% | +158.90% | +337.81% | 15.04B | |
| -0.36% | +0.13% | +43.52% | +166.48% | 14.46B | |
| +3.91% | -4.56% | -2.71% | +506.41% | 13.87B | |
| Average | +0.54% | -0.82% | +31.99% | +146.64% | 27.49B | |
| Weighted average by Cap. | +0.10% | -1.74% | +37.99% | +127.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 38.93M 34.36M 32.51M 29.48M 55.27M 3.74B 55.82M 390M 150M 1.91B 146M 143M 6.14B |
| Net income | - | - |
| Net Debt | 96.08M 84.79M 80.22M 72.75M 136M 9.22B 138M 962M 371M 4.71B 361M 353M 15.15B | 125M 110M 104M 94.61M 177M 11.99B 179M 1.25B 482M 6.12B 469M 459M 19.7B |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | US$0.1525 | -4.69% | 3,918,070 |
| 26-09-25 | US$0.1600 | +0.25% | 2,348,226 |
| 26-09-24 | US$0.1596 | -0.03% | 2,391,461 |
| 26-09-23 | US$0.1597 | -2.06% | 2,443,603 |
| 26-09-22 | US$0.1630 | -2.40% | 2,778,235 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1525USD
Average target price
1.000USD
Spread / Average Target
+555.74%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
